68856-96-2

Basic information

• Product Name: BOC-D-TYR(ME)-OH
• Synonyms: (2R)-3-(4-methoxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;Boc-O-methyl-D-tyrosine≥ 98% (HPLC);Boc-π-methoxy-D-Phe-OH;(R)-2-TERT-BUTOXYCARBONYLAMINO-3-(4-METHOXY-PHENYL)-PROPIONIC ACID;N-ALPHA-T-BUTOXYCARBONYL-4-METHOXY-D-PHENYLALANINE;N-ALPHA-T-BOC-O-METHYL-D-TYROSINE;N-ALPHA-T-BOC-P-METHOXY-D-PHENYLALANINE;N-ALPHA-T-BUTOXYCARBONYL-O-METHYL-D-TYROSINE
• CAS NO: 68856-96-2
• Molecular Formula: C₁₅H₂₁NO₅
• Molecular Weight: 295.33
• Product Categories: Unusual Amino Acids;Boc-Amino Acids and Derivative
• Mol File: 68856-96-2.mol
• Article Data: 4

Chemical Properties

• Melting Point: 93.0 to 97.0 °C
• Boiling Point: 462.0±40.0 °C(Predicted)
• Appearance: /
• Density: 1.168±0.06 g/cm3(Predicted)
• Storage Temp.: Store at 0-5°C
• PKA: 3.00±0.10(Predicted)
• CAS DataBase Reference: BOC-D-TYR(ME)-OH(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-D-TYR(ME)-OH(68856-96-2)
• EPA Substance Registry System: BOC-D-TYR(ME)-OH(68856-96-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 68856-96-2(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Uses

Boc-O-methyl-D-tyrosine is a compound involved in the design and synthesis of β-sheet-based self-assembling cyclic peptides with tunable cavities.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 122517-80-0 (2S,3R)-(-)-methyl 2,3-dihydroxy-3-(p-methoxyphenyl)propionate 
• 1415012-34-8 methyl 2-azido-3-(4-methoxyphenyl)propanoate 
• 1415012-33-7 methyl 2-bromo-3-(4-methoxyphenyl)propanoate 
• 58236-76-3 3-chloro-4-methoxy cinnamic acid 
• 122517-81-1 (2R,3S)-methyl 2,3-dihydroxy-3-(4-methoxyphenyl)propanoate 
• 832-01-9 methyl p-methoxycinnamate 
• 830-09-1 3-(4'-methoxyphenyl)propenoic acid 
• 241153-85-5 methyl 3-(3-chloro-4-methoxyphenyl)acrylate 
• 215454-88-9 N-tert.-butoxycarbonyl-2-(R)-amino-3-(4-methoxyphenyl)-propionic acid benzyl ester 
• 3728-20-9 D-tyrosine methylester hydrochloride 
• 76757-90-9 N-(tert-butoxycarbonyl)-D-tyrosine methyl ester 
• 556-02-5 tyrosine 
• 94790-24-6 (2R)-tert-butoxycarbonylamino-3-(4-methoxyphenyl)propionic acid methyl ester 

Downstream Products

• 178977-40-7 (R)-3-[(R)-2-tert-Butoxycarbonylamino-3-(4-methoxy-phenyl)-propionylamino]-2-methyl-propionic acid 
• 219606-83-4 benzyl (2S)-2-[3-[(2R)-2-tert-butoxycarbonylamino-3-(4-methoxyphenyl)propionylamino]-propionyloxy]-4-methylpentanoate 
• 70601-64-8 (R)-4-methoxyphenylalanine methyl ester hydrochloride 
• 350245-17-9 (R)-(tert-butoxy)-(N-1-((4-methoxyphenyl)methyl)-2-oxo-2-(2-oxoazetidinyl)ethyl)formamide 
• 728032-80-2 benzyl (2R)-2-[3-[(2R)-2-tert-butoxycarbonylamino-3-(4-methoxyphenyl)propionylamino]propionyloxy]-4-methylpentanoate 
• 139397-31-2 (4R,5S)-3-tert-butoxy-carbonyl-2,2-dimethyl-4-[(4-methoxyphenyl)methyl]-5-oxazolidine carboxylic acid 
• 1380302-31-7 C₄₄H₆₃N₅O₉ 
• 1198162-59-2 Boc-D-Tyr(Me)-L-γ-(Me)N-Acp-OFm 
• 1416468-60-4 tert-butyl [(2R)-1-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-3-(4-methoxyphenyl)-1-oxopropan-2-yl]carbamate 
• 1416468-50-2 (4aS,8aR)-2-{1-[(2R)-2-amino-3-(4-methoxyphenyl)propanoyl]piperidin-4-yl}-4-(3,4-dimethoxyphenyl)-4a,5,6,7,8,8a-hexahydrophthalazin-1(2H)-one hydrochloride 
• 1417342-73-4 tert-butyl [(R)-2-(3-cyclopropylmethoxy-3-o-tolylazetidin-1-yl)-1-(4-methoxybenzyl)-2-oxoethyl]carbamate 
• 1417342-78-9 tert-butyl [(R)-2-[3-(4-benzyloxybutoxy)-3-o-tolylazetidin-1-yl]-1-(4-methoxybenzyl)-2-oxoethyl]carbamate 
• 1416467-62-3 4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(2S)-1-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-3-(4-methoxyphenyl)-1-oxopropan-2-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide 
• 1416467-33-8 4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(2R)-1-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-3-(4-methoxyphenyl)-1-oxopropan-2-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide 

Relevant articles and documents

Synthesis of unit-B of cryptophycin-24 via Sharpless asymmetric dihydroxylation

A synthetic pathway for the synthesis of unit-B of cryptophycin-24 has been developed using Sharpless asymmetric dihydroxylation as the key step. This study shows that direct azidation of α-hydroxy acid ester using diphenylphosphoryl azide is beneficial to asymmetric synthesis of α-amino acid without the loss of chirality during the transformation.

Heterocyclic derivatives and their use as antithrombotic agents

The present invention relates to antithrombotic compounds comprising the group Q, Q having formula (I), wherein the substructure (i) is a structure selected from (a, b and c), wherein X is O or S; X′ being independently CH or N; and m is 0, 1, 2 or 3; wherein the group Q is bound through an oxygen atom or an optionally substituted nitrogen or carbon atom, or a pharmaceutically acceptable salt thereof or a prodrug thereof. The compounds of the invention are therapeutically active and in particular are antithrombotic agents.